Ida Daniela Perrotta
Overview
Explore the profile of Ida Daniela Perrotta including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
76
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mazzotta E, Romeo M, Sacco G, De Benedittis S, Qualtieri A, Perrotta I, et al.
Molecules
. 2025 Mar;
30(5).
PMID: 40076371
This study was designed to develop cationic vesicles for doxorubicin (DOX) delivery and to compare anticancer efficacy of these systems uncoated and coated with hyaluronic acid. Cationic nanoformulation was first...
2.
Mazzotta E, Romeo M, Hafidi Z, Perez L, Perrotta I, Muzzalupo R
Pharmaceutics
. 2024 Jul;
16(7).
PMID: 39065606
In the current study, a smart release system responsive to temperature was developed to improve the efficiency of tetracycline (TC) in antibacterial therapy. The nanovesicles designed consist of a non-ionic...
3.
Bossio S, Perrotta I, Lofaro D, La Russa D, Rago V, Bonofiglio R, et al.
Genes (Basel)
. 2024 Jul;
15(7).
PMID: 39062726
Anderson-Fabry disease (AFD) is an X-linked multisystemic disorder with a heterogeneous phenotype, resulting from deficiency of the lysosomal enzyme α-galactosidase A (α-Gal A) and leading to globotriaosylceramide systemic accumulation. Lysosomal...
4.
Torcasio R, Gallo Cantafio M, Veneziano C, De Marco C, Ganino L, Valentino I, et al.
J Transl Med
. 2024 Feb;
22(1):208.
PMID: 38413989
Background: Mitochondrial alterations, often dependent on unbalanced mitochondrial dynamics, feature in the pathobiology of human cancers, including multiple myeloma (MM). Flavanones are natural flavonoids endowed with mitochondrial targeting activities. Herein,...
5.
Di Vito A, Chiarella E, Sovereto J, Bria J, Perrotta I, Salatino A, et al.
Eur J Cell Biol
. 2023 Aug;
102(4):151354.
PMID: 37604089
Alendronate (ALN) is a second-generation bisphosphonate widely used for osteoporosis and cancer-induced bone lesions. Many studies have confirmed a strong relationship between osteonecrosis of the jaws (ONJ) development and oral...
6.
Talia M, Cirillo F, Spinelli A, Zicarelli A, Scordamaglia D, Muglia L, et al.
J Exp Clin Cancer Res
. 2023 Jul;
42(1):164.
PMID: 37434266
Background: The receptor for advanced glycation-end products (RAGE) and its ligands have been implicated in obesity and associated inflammatory processes as well as in metabolic alterations like diabetes. In addition,...
7.
Candreva A, De Rose R, Perrotta I, Guglielmelli A, La Deda M
Nanomaterials (Basel)
. 2023 Feb;
13(4).
PMID: 36839113
Metallic nanoparticles show plasmon resonance phenomena when irradiated with electromagnetic radiation of a suitable wavelength, whose value depends on their composition, size, and shape. The damping of the surface electron...
8.
Romeo M, Mazzotta E, Perrotta I, Muzzalupo R
Pharmaceutics
. 2022 Oct;
14(10).
PMID: 36297625
Lidocaine is a local anaesthetic drug with an amphiphilic structure able to self-associate, under certain conditions, in molecular aggregates playing the role of both carrier and drug. The aim of...
9.
Morelli E, Hunter Z, Fulciniti M, Gulla A, Perrotta I, Zuccala V, et al.
Exp Hematol Oncol
. 2022 Sep;
11(1):54.
PMID: 36096954
Activating G protein-coupled estrogen receptor 1 (GPER1) is an attractive therapeutic strategy for treating a variety of human diseases including cancer. Here, we show that GPER1 is significantly upregulated in...
10.
Battaglia A, Sacco A, Perrotta I, Faniello M, Scalise M, Torella D, et al.
Front Oncol
. 2022 Apr;
12:868351.
PMID: 35433479
Objectives: Developing novel therapeutic approaches to defeat chemoresistance is the major goal of ovarian cancer research. Induction of ferroptosis has shown promising antitumor effects in ovarian cancer cells, but the...